NCT07787052 R-GASTIM- Study of Gastric Cancer Operable
| NCT ID | NCT07787052 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Leon Berard |
| Condition | Gastric Cancers |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-09-30 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-09-30 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Clinicobiological cohort of gastric cancers operated in our institution.
Eligibility Criteria
Inclusion Criteria: * Adult patients with histologically proven non-metastatic resectable gastric and gastroesophageal junction adenocarcinoma, Stage IB to III be treated with standard neoadjuvant chemotherapy * Knwon response to neoadjuvant chemotherapy as per TRG criteria * Surgery of primary tumor done at Centre Léon Bérard. Availability of archival FFPE tumor block from initial diagnosis with at least 20% of tumor cells and collected lymp nodes Exclusion Criteria: * Patient refusal to participate to this clinicobiological cohort
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07787052 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gastric Cancers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07787052 currently recruiting?
Yes, NCT07787052 is actively recruiting participants. Contact the research team at clelia.coutzac@lyon.unicancer.fr for enrollment information.
Where is the NCT07787052 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT07787052 clinical trial?
NCT07787052 is sponsored by Centre Leon Berard. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.